CAS 919783-22-5

Benzamide,3-[[5-(1-azetidinylcarbonyl)-2-pyrazinyl]oxy]-5-[(1S)-2-methoxy-1-methylethoxy]-N-(5-methyl-2-pyrazinyl)-

Description:

Benzamide, 3-[[5-(1-azetidinylcarbonyl)-2-pyrazinyl]oxy]-5-[(1S)-2-methoxy-1-methylethoxy]-N-(5-methyl-2-pyrazinyl)-, identified by CAS number 919783-22-5, is a complex organic compound characterized by its unique structural features. It contains a benzamide core, which is a derivative of benzoic acid where the carboxylic acid group is replaced by an amide group. The presence of multiple functional groups, including pyrazine rings and an azetidine moiety, suggests potential biological activity, possibly as a pharmaceutical agent. The methoxy and methylethoxy substituents indicate that the compound may exhibit specific solubility and reactivity properties. Its molecular structure implies that it could interact with biological targets, making it of interest in medicinal chemistry. Additionally, the compound's synthesis and characterization would involve standard organic chemistry techniques, including spectroscopic methods for confirmation of its structure. Overall, this compound exemplifies the complexity often found in drug design, where multiple pharmacophores are combined to enhance efficacy and selectivity.

Formula: C₂₄H₂₆N₆O₅

AZD1656

CAS: 919783-22-5

Formula: C₂₄H₂₆N₆O₅

Purity: 98%

Molecular weight: 478.5004

Ref: IN-DA01FW6P

AZD-1656

CAS: 919783-22-5

AZD-1656

Purity: ≥95%

Molecular weight: 478.5g/mol

Ref: 54-BUP01955

AZD 1656

CAS: 919783-22-5

Glucokinase activator

Formula: C₂₄H₂₆N₆O₆

Purity: Min. 95%

Molecular weight: 494.5 g/mol

Ref: 3D-BA171838

AZD-1656

CAS: 919783-22-5

AZD-1656 is a glucokinase activator (GKA) that can cause dose-limiting hypoglycemia in normal animals used in embryofetal development studies and type 2

Formula: C₂₄H₂₆N₆O₅

Purity: 97.07% - 99.37%

Color and Shape: Solid

Molecular weight: 478.5

Ref: TM-T26712